FDA Inspection 808907 — Prinston Pharmaceutical Inc.
The FDA completed an inspection of Prinston Pharmaceutical Inc. on November 30, 2012 in Somerset, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 30, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Somerset, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)